Espoo, Finland

Fermion Oy

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 83.3



Forward Citations = 13

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Arne Grumann (6 out of 8 patents)

silverMedal Ilpo Laitinen (4 out of 7 patents)

bronzeMedal Soini Huhta (4 out of 4 patents)

4.  Petteri Rummakko (4 out of 15 patents)

5.  Jan Tois (2 out of 2 patents)

6.  Antti Piisola (1 out of 1 patent)

7.  Antti Kataja (1 out of 1 patent)

8.  Ainoliisa Pihko (1 out of 1 patent)

9.  Viesturs Lusis (1 out of 3 patents)

10.  Dzintra Muceniece (1 out of 3 patents)

11.  Otto Soidinsalo (1 out of 1 patent)

12.  Tuomas Koiranen (1 out of 1 patent)

13.  Leif Hilden (1 out of 4 patents)

14.  Hannele Nikander (1 out of 3 patents)


12 patents:

Company Overview
Fermion Oy is a Finnish company specializing in the development and manufacturing of advanced pharmaceutical products. With a focus on high-quality active pharmaceutical ingredients (APIs), Fermion plays a significant role in the global pharmaceutical supply chain. The company is dedicated to innovation in drug formulation and production processes, ensuring compliance with stringent regulatory standards. Located in Espoo, Fermion leverages its expertise to support both local and international markets in delivering effective healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

12 Patents

#57 in Espoo

#255 in Finland

#48,276 in the World

Espoo, FI
Espoo, Finland
Forward Citations = 13

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fermion Oy. Retrieved from https://idiyas.com/company/fermion-oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…